Tools
Chromosome Instability Syndromes
Introduction
Chromosomal instability syndromes are a group of inherited disorders associated with chromosomal instability and breakage spontaneously or in response to DNA-damaging agents.[1] Most of these syndromes are significant because they are associated with variable degrees of immunodeficiency, infectious disease, and the risk of developing certain malignancies.[2] The following chromosomal instability syndromes are rare but well-described:
Other rare syndromes include ataxia telangiectasia-like disorder; immunodeficiency, centromeric instability, and facial anomalies syndromes; Cockayne syndrome; trichothiodystrophy; xeroderma pigmentosum; DNA ligase I deficiency; PMS2 deficiency; and DNA recombinase repair defects (DNA-PKcs, Artemis, DNA ligase 4, Cernunnos/XLF).[7][8][9][10][11][12][13]
Etiology
Register For Free And Read The Full Article
Search engine and full access to all medical articles- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Etiology
Chromosomal instability syndromes show chromosomal instability because defective proteins or enzymes spontaneously lead to chromosomal breakage or in response to DNA-damaging agents. [2]
Epidemiology
Incidence rates for the following rare chromosomal instability syndromes are:
- Ataxia-telangiectasia: 1 in 40,000 to 100,000 live births [14]
- Bloom syndrome: Reported across different ethnicities but is common in Eastern European (Ashkenazi) Jews; estimated carrier frequency of 1 in 120 [15][16]
- Fanconi anemia: Although a rare syndrome, it's a common inherited bone marrow failure syndrome; cases are reported across all racial and ethnic groups.[17]
- Nijmegen breakage syndrome: More common in individuals with Eastern European ancestry [18]
Pathophysiology
Although the pathophysiology of these disorders is secondary to different deficits, the final common pathway to chromosomal instability is due to an increased risk of DNA damage or defective DNA repair mechanisms.
Ataxia-Telangiectasia
Ataxia-telangiectasia is an autosomal recessive disorder that primarily presents with cerebellar ataxia. It results from a mutation in the ataxia telangiectasia mutated (ATM) gene, which leads to a total loss of ATM protein (classic type) or a reduction of its level (wild-type).[3] In normal conditions, the ATM protein recognizes DNA damage and activates DNA repair mechanisms to reduce genetic damage. The defect in the regulatory functions of the ATM gene causes somatic mutations that lead to the manifestations of the disease.
Bloom Syndrome
Bloom syndrome is an autosomal recessive disease caused by a lack of BLM helicase enzyme, resulting from a mutation in the BLM gene. BLM gene encodes a RecQ helicase and RECQL3, referred to as the Bloom syndrome protein (BLM), which helps maintain DNA stability, especially during recombination repair and replication. The protein is also involved with other molecules involved in DNA damage surveillance and repair.[19][20]
Fanconi Anemia
Fanconi anemia is a DNA repair disorder where cells cannot repair DNA damage caused by interstrand cross-links (ICLs). This defect eventually leads to chromosomal instability, particularly upon exposure to cytotoxic therapies, and a general predisposition to certain cancers. Fanconi anemia can result from a mutation in any of the 17 different Fanconi anemia genes (FANCA to FANCQ). The most commonly mutated genes in patients with Fanconi anemia are FANCA, FANCC, and FANCG. Inheritance patterns include autosomal recessive, autosomal dominant, and X-linked.[17]
Nijmegen Breakage Syndrome
Nijmegen breakage syndrome is an autosomal recessive chromosome instability syndrome associated with immunodeficiency. Nijmegen breakage syndrome results from mutations in the nibrin (NBN) gene on 8q21. The protein product is involved in DNA double-strand breaks repair, base excision repair, meiotic recombination, and telomere maintenance.[21][22]
History and Physical
Ataxia-Telangiectasia
In classic form, ataxia-telangiectasia patients present early with ataxia (gait impairment, hand incoordination, and eye movement dysfunction), and conjunctival telangiectasias occur during school age.[23] Recurrent sinopulmonary infections are secondary to the reduction of immunoglobulins and the reduction of newly produced B and T cells.[24] These infections can further progress into bronchiectasis and pulmonary fibrosis. Young adults have an increased risk of hematological malignancies, including lymphoma and leukemia.[25][26] Other cancers, such as breast, liver, and esophageal cancer, are also possible. There is also a higher incidence of diabetes mellitus. Neurological manifestations occur later in life with dystonia and choreoathetosis.[23]
Bloom Syndrome
Bloom syndrome patients can present with a variable combination of symptoms that include disproportionately short stature, microcephaly, immunodeficiency, sinopulmonary infections, decreased intellectual ability, facial anomalies, an erythematous rash associated with sun exposure, café-au-lait spot/hypopigmented skin lesions, infertility, a predisposition to hematological malignancies, solid carcinomas and insulin resistance. Short stature is the most striking early symptom that usually drives patients to medical attention.[19][27][16]
Fanconi Anemia
Fanconi anemia is an inherited bone marrow failure condition characterized by pancytopenia, cancer predisposition, short stature, microcephaly, developmental delay, and variable anomalies. Anomalies in FA include:
- Skin hyper- or hypopigmentation
- Thumb or other radial ray abnormalities
- Hand abnormalities such as clinodactyly
- Axial skeletal abnormalities such as short or webbed neck and vertebral anomalies
- Eye malformations
- Renal and urinary tract malformations
- Gonadal/genital malformations
- Ear abnormalities such as middle ear anomalies or atretic ear canal
- Congenital heart disease, including patent ductus arteriosus and ventricular septal defect
- Gastrointestinal anomalies and central nervous system abnormalities [28][29]
Nijmegen Breakage Syndrome
Nijmegen breakage syndrome shows progressive symptoms that include microcephaly, facial deformities with "bird-like" faces, intrauterine growth retardation, intellectual disability, immunodeficiency with recurrent sinopulmonary infections, a predisposition to lymphoid malignancies, primary ovarian insufficiency, and radiosensitivity.[30]
Evaluation
Ataxia-Telangiectasia
Diagnostic evaluation for ataxia-telangiectasia includes a combination of ataxia with 1 or more of the following: telangiectasia, sinopulmonary disease, or imaging studies (especially with brain MRI) showing diffuse cerebellar atrophy. Investigations for ataxia-telangiectasia should include a complete blood count with lymphopenia; serological testing shows increased alpha-fetoprotein (the most consistent test in ataxia-telangiectasia)[31] and decreased immunoglobulin (Ig)A, IgG, and IgE. The most specific test is testing for the genetic mutation in the ATM gene or lack of ATM protein kinase. Of note, antenatal diagnosis is possible by identifying ATM gene mutation.[23]
Bloom Syndrome
Investigation for Bloom syndrome focuses on the assessment of immunodeficiency. Tests include serology testing and CBC. Serological testing shows decreased immunoglobulin levels (IgA, IgG, and IgE). CBC shows lymphopenia.
Fanconi Anemia
Investigation for FA includes chromosomal stress testing and next-generation sequencing (NGS) panels. Chromosomal stress testing involves the assessment of chromosomal breakage in T-lymphocytes from peripheral blood upon exposure of cells to diepoxybutane (DEB) or mitomycin C (MMC). The test is sensitive but not specific because other rare genetic diseases can also show breakage. Flow cytometry, which assesses cell cycle analysis upon exposure to DNA cross-linking agents, is another helpful test in evaluating FA. In FA, cells cannot repair DNA damage and undergo cell cycle arrest in G2, leading to a higher percentage of cells in G2. Fanconi anemia gene sequencing is generally used as a confirmatory tool for patients with positive breakage studies.[32]
Nijmegen Breakage Syndrome
Investigation for Nijmegen breakage syndrome focuses on the assessment of immunodeficiency. Tests include assessment of immunoglobulin levels, CD4, CD8, CD19, CD57, and class switching of memory B cells. Karyotyping sometimes shows structural chromosomal aberrations in T=lymphocytes at chromosomes 7 and 14. There is also sensitivity to ionizing radiation. There are also mutations in the NBN gene and the absence of fibrin protein.[30]
Treatment / Management
Ataxia-Telangiectasia
Treatment of ataxia-telangiectasia is symptomatic and supportive. It includes physical rehabilitation to cope with the ataxia, prompt treatment of infections, and management of diabetes mellitus.
Bloom Syndrome
Treatment of Bloom syndrome is symptomatic and includes immediate treatment of infections and periodic surveillance for cancer. Patients should avoid sun and radiation exposure.
Fanconi Anemia
Management of Fanconi anemia focuses on managing bone marrow failure, cancer surveillance, and control of organ dysfunction. The only curative option for FA is allogeneic hematopoietic cell transplantation (HCT). Supportive therapeutic options include androgen therapy to increase blood cell count, the use of granulocyte colony-stimulating factor, and blood product transfusions.[33]
Nijmegen Breakage Syndrome
Management of Nijmegen breakage syndrome focuses on symptomatic treatment. Prompt management of immunodeficiency as appropriate with antibiotics and IV immunoglobulins[34] to reduce morbidity and mortality in Nijmegen breakage syndrome patients.
Differential Diagnosis
Ataxia-Telangiectasia
The differential diagnoses of ataxia-telangiectasia include:
- Cerebral palsy
- Friedreich ataxia
- Gaucher disease
- Niemann-Pick disease.
Bloom Syndrome
The differential diagnoses of Bloom syndrome include other disorders that present with short stature, including:
- Skeletal dysplasia
- Growth hormone deficiency
- Constitutional delay.
Fanconi Anemia
The differential diagnoses of Fanconi anemia include other diseases presenting with bone marrow failure, such as:
- Acquired aplastic anemia
- Paroxysmal nocturnal hemoglobinuria
- Other inherited bone marrow failure syndromes
- Drug-induced or infection-associated pancytopenia
- Nijmegen breakage syndrome
- Bloom syndrome
- Ataxia-telangiectasia
- LIG4 syndrome (LIG4)
- NHEJ1 deficiency (NHEJ1)
- Seckel syndrome (ATR)
- Roberts syndrome (ESCO2)
- Warsaw breakage syndrome (DDX11)
- De novo myelodysplastic syndrome (MDS)
Nijmegen breakage syndrome
The differential diagnoses of Nijmegen breakage syndrome include:
- Ataxia-telangiectasia
- Ataxia-telangiectasia–like disease
- Fanconi anemia
- Bloom syndrome
- RAD50 deficiency
- Seckel syndrome.[35][36]
Cancers in Chromosomal Instability Disorders
Differentials for cancers in chromosomal instability disorders include cancer syndromes secondary to oncogene and tumor suppressor gene mutations.[37][38]
Prognosis
The prognoses for these chromosomal instability syndromes are as follows:
- Ataxia-Telangiectasia: Variable rate of progression; with the classic form, most patients have a poor quality of life and high mortality by early adulthood.
- Bloom Syndrome: Most patients with Bloom syndrome survive to adulthood; cancer surveillance has demonstrated an association with improved outcomes.
- Fanconi anemia: Stratified and managed based on the severity of bone marrow failure.
- Nijmegen breakage syndrome: Depends on the severity of the patient's symptoms and management strategies of infections.
Complications
Complications of chromosomal instability include an increased predisposition to cancer, infections, and organ dysfunction.
Deterrence and Patient Education
Many chromosomal instability syndromes run in families; early management can be the key to a better prognosis for these patients.
Enhancing Healthcare Team Outcomes
Chromosomal instability syndromes are rare disease entities that need interprofessional team management, including genetic counseling, infectious disease consultation, and tailored cancer surveillance programs.
References
Taylor AM. Chromosome instability syndromes. Best practice & research. Clinical haematology. 2001 Sep:14(3):631-44 [PubMed PMID: 11640873]
Level 3 (low-level) evidenceTaylor AMR, Rothblum-Oviatt C, Ellis NA, Hickson ID, Meyer S, Crawford TO, Smogorzewska A, Pietrucha B, Weemaes C, Stewart GS. Chromosome instability syndromes. Nature reviews. Disease primers. 2019 Sep 19:5(1):64. doi: 10.1038/s41572-019-0113-0. Epub 2019 Sep 19 [PubMed PMID: 31537806]
Perlman S, Becker-Catania S, Gatti RA. Ataxia-telangiectasia: diagnosis and treatment. Seminars in pediatric neurology. 2003 Sep:10(3):173-82 [PubMed PMID: 14653405]
Amor-Guéret M, Bloom syndrome, genomic instability and cancer: the SOS-like hypothesis. Cancer letters. 2006 May 8; [PubMed PMID: 15950375]
Level 3 (low-level) evidenceWu ZH. The concept and practice of Fanconi Anemia: from the clinical bedside to the laboratory bench. Translational pediatrics. 2013 Jul:2(3):112-9. doi: 10.3978/j.issn.2224-4336.2013.07.01. Epub [PubMed PMID: 26835301]
Weemaes CM, Hustinx TW, Scheres JM, van Munster PJ, Bakkeren JA, Taalman RD. A new chromosomal instability disorder: the Nijmegen breakage syndrome. Acta paediatrica Scandinavica. 1981 Jul:70(4):557-64 [PubMed PMID: 7315300]
Level 3 (low-level) evidenceStewart GS, Maser RS, Stankovic T, Bressan DA, Kaplan MI, Jaspers NG, Raams A, Byrd PJ, Petrini JH, Taylor AM. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell. 1999 Dec 10:99(6):577-87 [PubMed PMID: 10612394]
Weemaes CM,van Tol MJ,Wang J,van Ostaijen-ten Dam MM,van Eggermond MC,Thijssen PE,Aytekin C,Brunetti-Pierri N,van der Burg M,Graham Davies E,Ferster A,Furthner D,Gimelli G,Gennery A,Kloeckener-Gruissem B,Meyn S,Powell C,Reisli I,Schuetz C,Schulz A,Shugar A,van den Elsen PJ,van der Maarel SM, Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects. European journal of human genetics : EJHG. 2013 Nov; [PubMed PMID: 23486536]
Karikkineth AC, Scheibye-Knudsen M, Fivenson E, Croteau DL, Bohr VA. Cockayne syndrome: Clinical features, model systems and pathways. Ageing research reviews. 2017 Jan:33():3-17. doi: 10.1016/j.arr.2016.08.002. Epub 2016 Aug 6 [PubMed PMID: 27507608]
Kraemer KH, Patronas NJ, Schiffmann R, Brooks BP, Tamura D, DiGiovanna JJ. Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience. 2007 Apr 14:145(4):1388-96 [PubMed PMID: 17276014]
Soza S, Leva V, Vago R, Ferrari G, Mazzini G, Biamonti G, Montecucco A. DNA ligase I deficiency leads to replication-dependent DNA damage and impacts cell morphology without blocking cell cycle progression. Molecular and cellular biology. 2009 Apr:29(8):2032-41. doi: 10.1128/MCB.01730-08. Epub 2009 Feb 17 [PubMed PMID: 19223467]
Wimmer K,Kratz CP, Constitutional mismatch repair-deficiency syndrome. Haematologica. 2010 May; [PubMed PMID: 20442441]
Tsai CJ, Kim SA, Chu G. Cernunnos/XLF promotes the ligation of mismatched and noncohesive DNA ends. Proceedings of the National Academy of Sciences of the United States of America. 2007 May 8:104(19):7851-6 [PubMed PMID: 17470781]
Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM. Ataxia telangiectasia: a review. Orphanet journal of rare diseases. 2016 Nov 25:11(1):159 [PubMed PMID: 27884168]
Shahrabani-Gargir L, Shomrat R, Yaron Y, Orr-Urtreger A, Groden J, Legum C. High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin. Genetic testing. 1998:2(4):293-6 [PubMed PMID: 10464606]
Cunniff C,Bassetti JA,Ellis NA, Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition. Molecular syndromology. 2017 Jan [PubMed PMID: 28232778]
de Winter JP, Joenje H. The genetic and molecular basis of Fanconi anemia. Mutation research. 2009 Jul 31:668(1-2):11-9. doi: 10.1016/j.mrfmmm.2008.11.004. Epub 2008 Nov 14 [PubMed PMID: 19061902]
Varon R, Seemanova E, Chrzanowska K, Hnateyko O, Piekutowska-Abramczuk D, Krajewska-Walasek M, Sykut-Cegielska J, Sperling K, Reis A. Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations. European journal of human genetics : EJHG. 2000 Nov:8(11):900-2 [PubMed PMID: 11093281]
German J, Sanz MM, Ciocci S, Ye TZ, Ellis NA. Syndrome-causing mutations of the BLM gene in persons in the Bloom's Syndrome Registry. Human mutation. 2007 Aug:28(8):743-53 [PubMed PMID: 17407155]
Naim V,Rosselli F, The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities. Nature cell biology. 2009 Jun [PubMed PMID: 19465921]
Sagan D, Müller R, Kröger C, Hematulin A, Mörtl S, Eckardt-Schupp F. The DNA repair protein NBS1 influences the base excision repair pathway. Carcinogenesis. 2009 Mar:30(3):408-15. doi: 10.1093/carcin/bgp004. Epub 2009 Jan 6 [PubMed PMID: 19126654]
Digweed M, Sperling K. Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks. DNA repair. 2004 Aug-Sep:3(8-9):1207-17 [PubMed PMID: 15279809]
Verhagen MM, Abdo WF, Willemsen MA, Hogervorst FB, Smeets DF, Hiel JA, Brunt ER, van Rijn MA, Majoor Krakauer D, Oldenburg RA, Broeks A, Last JI, van't Veer LJ, Tijssen MA, Dubois AM, Kremer HP, Weemaes CM, Taylor AM, van Deuren M. Clinical spectrum of ataxia-telangiectasia in adulthood. Neurology. 2009 Aug 11:73(6):430-7. doi: 10.1212/WNL.0b013e3181af33bd. Epub 2009 Jun 17 [PubMed PMID: 19535770]
Level 2 (mid-level) evidenceStaples ER, McDermott EM, Reiman A, Byrd PJ, Ritchie S, Taylor AM, Davies EG. Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene. Clinical and experimental immunology. 2008 Aug:153(2):214-20. doi: 10.1111/j.1365-2249.2008.03684.x. Epub 2008 May 26 [PubMed PMID: 18505428]
Level 2 (mid-level) evidenceBoultwood J. Ataxia telangiectasia gene mutations in leukaemia and lymphoma. Journal of clinical pathology. 2001 Jul:54(7):512-6 [PubMed PMID: 11429421]
Level 3 (low-level) evidenceTaylor AM, Metcalfe JA, Thick J, Mak YF. Leukemia and lymphoma in ataxia telangiectasia. Blood. 1996 Jan 15:87(2):423-38 [PubMed PMID: 8555463]
Van Kerckhove CW, Ceuppens JL, Vanderschueren-Lodeweyckx M, Eggermont E, Vertessen S, Stevens EA. Bloom's syndrome. Clinical features and immunologic abnormalities of four patients. American journal of diseases of children (1960). 1988 Oct:142(10):1089-93 [PubMed PMID: 3263039]
Soulier J. Fanconi anemia. Hematology. American Society of Hematology. Education Program. 2011:2011():492-7. doi: 10.1182/asheducation-2011.1.492. Epub [PubMed PMID: 22160080]
Garaycoechea JI, Patel KJ. Why does the bone marrow fail in Fanconi anemia? Blood. 2014 Jan 2:123(1):26-34. doi: 10.1182/blood-2013-09-427740. Epub 2013 Nov 7 [PubMed PMID: 24200684]
Level 3 (low-level) evidenceChrzanowska KH, Gregorek H, Dembowska-Bagińska B, Kalina MA, Digweed M. Nijmegen breakage syndrome (NBS). Orphanet journal of rare diseases. 2012 Feb 28:7():13. doi: 10.1186/1750-1172-7-13. Epub 2012 Feb 28 [PubMed PMID: 22373003]
Stray-Pedersen A, Borresen-Dale AL, Paus E, Lindman CR, Burgers T, Abrahamsen TG. Alpha fetoprotein is increasing with age in ataxia-telangiectasia. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. 2007 Nov:11(6):375-80 [PubMed PMID: 17540590]
Oostra AB, Nieuwint AW, Joenje H, de Winter JP. Diagnosis of fanconi anemia: chromosomal breakage analysis. Anemia. 2012:2012():238731. doi: 10.1155/2012/238731. Epub 2012 May 24 [PubMed PMID: 22693659]
MacMillan ML, Wagner JE. Haematopoeitic cell transplantation for Fanconi anaemia - when and how? British journal of haematology. 2010 Apr:149(1):14-21. doi: 10.1111/j.1365-2141.2010.08078.x. Epub 2010 Feb 5 [PubMed PMID: 20136826]
Arumugham VB, Rayi A. Intravenous Immunoglobulin (IVIG). StatPearls. 2024 Jan:(): [PubMed PMID: 32119333]
Waltes R, Kalb R, Gatei M, Kijas AW, Stumm M, Sobeck A, Wieland B, Varon R, Lerenthal Y, Lavin MF, Schindler D, Dörk T. Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder. American journal of human genetics. 2009 May:84(5):605-16. doi: 10.1016/j.ajhg.2009.04.010. Epub 2009 Apr 30 [PubMed PMID: 19409520]
Level 3 (low-level) evidenceGriffith E, Walker S, Martin CA, Vagnarelli P, Stiff T, Vernay B, Al Sanna N, Saggar A, Hamel B, Earnshaw WC, Jeggo PA, Jackson AP, O'Driscoll M. Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling. Nature genetics. 2008 Feb:40(2):232-6 [PubMed PMID: 18157127]
Level 2 (mid-level) evidenceJoyce C, Rayi A, Kasi A. Tumor-Suppressor Genes. StatPearls. 2024 Jan:(): [PubMed PMID: 30335276]
Larsson LG. Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence. Seminars in cancer biology. 2011 Dec:21(6):367-76. doi: 10.1016/j.semcancer.2011.10.005. Epub 2011 Oct 24 [PubMed PMID: 22037160]